Search

Search Constraints

You searched for: Author/Creator Baas, Paul

Search Results

3. A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project. (May 2019)

5. Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions. Issue 1 (25th March 2019)

6. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010. Issue 9 (June 2015)

7. Corrigendum to "eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer" [Lung Cancer 160 (2021) 36–43]. (December 2021)

9. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Issue 10272 (30th January 2021)

10. First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743. (May 2022)